Suppr超能文献

多发性硬化症患者的体重状况:对活动能力结果的影响。

Weight status in persons with multiple sclerosis: implications for mobility outcomes.

作者信息

Pilutti Lara A, Dlugonski Deirdre, Pula John H, Motl Robert W

机构信息

Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, 233 Freer Hall, Urbana, IL 61801, USA.

出版信息

J Obes. 2012;2012:868256. doi: 10.1155/2012/868256. Epub 2012 Sep 25.

Abstract

The accumulation of excess body weight may have important health and disease consequences for persons with multiple sclerosis (MS). This study examined the effect of weight status on mobility using a comprehensive set of mobility outcomes including ambulatory performance (timed 25-foot walk, T25FW; 6-minute walk, 6MW; oxygen cost of walking, C(w); spatiotemporal parameters of gait; self-reported walking impairment, Multiple Sclerosis Walking Scale-12 (MSWS-12); and free-living activity, accelerometry) in 168 ambulatory persons with MS. Mean (SD) BMI was 27.7 (5.1) kg/m(2). Of the 168 participants, 31.0% were classified as normal weight (BMI = 18.5-24.9 kg/m(2)), 36.3% were classified as overweight (BMI = 25.0-29.9 kg/m(2)), and 32.7% were classified as obese, classes I and II (BMI = 30-39.9 kg/m(2)). There were no significant differences among BMI groups on T25FW and 6MW, C(w), spatiotemporal gait parameters, MSWS-12, or daily step and movement counts. The prevalence of overweight and obesity in this sample was almost 70%, but there was not a consistent nor significant impact of BMI on outcomes of mobility. The lack of an effect of weight status on mobility emphasizes the need to focus on and identify other factors which may be important targets of ambulatory performance in persons with MS.

摘要

体重超标对于多发性硬化症(MS)患者可能会产生重要的健康和疾病影响。本研究使用一套全面的移动性指标,包括动态表现(25英尺定时步行,T25FW;6分钟步行,6MW;步行耗氧量,C(w);步态的时空参数;自我报告的步行障碍,多发性硬化症步行量表-12(MSWS-12);以及自由生活活动,加速度计),对168名能行走的MS患者的体重状况对移动性的影响进行了研究。平均(标准差)体重指数(BMI)为27.7(5.1)kg/m²。在这168名参与者中,31.0%被归类为正常体重(BMI = 18.5 - 24.9 kg/m²),36.3%被归类为超重(BMI = 25.0 - 29.9 kg/m²),32.7%被归类为肥胖I级和II级(BMI = 30 - 39.9 kg/m²)。在T25FW、6MW、C(w)、时空步态参数、MSWS-12或每日步数和活动计数方面,BMI组之间没有显著差异。该样本中超重和肥胖的患病率近70%,但BMI对移动性结果没有一致且显著的影响。体重状况对移动性缺乏影响,这凸显了需要关注和识别其他可能是MS患者动态表现重要目标的因素。

相似文献

1
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
J Obes. 2012;2012:868256. doi: 10.1155/2012/868256. Epub 2012 Sep 25.
2
No association between body composition and walking outcomes in multiple sclerosis.
Mult Scler Relat Disord. 2022 Dec;68:104242. doi: 10.1016/j.msard.2022.104242. Epub 2022 Oct 17.
3
Accelerometry as a measure of walking behavior in multiple sclerosis.
Acta Neurol Scand. 2013 Jun;127(6):384-90. doi: 10.1111/ane.12036. Epub 2012 Dec 13.
4
Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters.
Arch Phys Med Rehabil. 2013 Mar;94(3):575-8. doi: 10.1016/j.apmr.2012.08.214. Epub 2012 Sep 5.
6
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
J Neurol Sci. 2013 Dec 15;335(1-2):169-73. doi: 10.1016/j.jns.2013.09.024. Epub 2013 Sep 24.
7
Do depressive and anxiety symptoms influence the construct validity of Multiple Sclerosis Walking Scale-12 scores?
Rehabil Psychol. 2024 May;69(2):129-134. doi: 10.1037/rep0000534. Epub 2024 Jan 1.
8
The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.
Mult Scler. 2013 Nov;19(13):1784-91. doi: 10.1177/1352458513483890. Epub 2013 Apr 15.
9
Self-efficacy and Walking Performance in Persons With Multiple Sclerosis.
J Neurol Phys Ther. 2017 Apr;41(2):114-118. doi: 10.1097/NPT.0000000000000172.
10
Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence.
Mult Scler Relat Disord. 2023 Mar;71:104552. doi: 10.1016/j.msard.2023.104552. Epub 2023 Feb 5.

引用本文的文献

3
Development and Cross-Validation of a Simple Model to Estimate Percent Body Fat in Persons with Multiple Sclerosis.
Int J MS Care. 2021 Sep-Oct;23(5):193-198. doi: 10.7224/1537-2073.2020-034. Epub 2021 Jan 12.
4
Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis.
Clinicoecon Outcomes Res. 2021 Oct 11;13:883-892. doi: 10.2147/CEOR.S330118. eCollection 2021.
5
The Relationship Between Walking Speed and the Energetic Cost of Walking in Persons With Multiple Sclerosis and Healthy Controls: A Systematic Review.
Neurorehabil Neural Repair. 2021 Jun;35(6):486-500. doi: 10.1177/15459683211005028. Epub 2021 Apr 13.
6
Comfortable walking speed and energy cost of locomotion in patients with multiple sclerosis.
Eur J Appl Physiol. 2020 Mar;120(3):551-566. doi: 10.1007/s00421-019-04295-3. Epub 2020 Jan 9.
7
Depressive Symptoms in Bariatric Surgery Patients with Multiple Sclerosis.
Obes Surg. 2018 Apr;28(4):1091-1097. doi: 10.1007/s11695-017-2977-y.
8
Outcomes of Bariatric Surgery in Morbidly Obese Patients with Multiple Sclerosis.
J Obes. 2017;2017:1935204. doi: 10.1155/2017/1935204. Epub 2017 Feb 19.
9
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.
Mult Scler. 2017 Apr;23(5):704-710. doi: 10.1177/1352458517690823. Epub 2017 Feb 16.
10
Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.
PLoS One. 2016 Apr 28;11(4):e0154335. doi: 10.1371/journal.pone.0154335. eCollection 2016.

本文引用的文献

1
Weight status and disability in multiple sclerosis: An examination of bi-directional associations over a 24-month period.
Mult Scler Relat Disord. 2012 Jul;1(3):139-44. doi: 10.1016/j.msard.2012.02.004. Epub 2012 Mar 28.
2
Energy cost of walking and its association with gait parameters, daily activity, and fatigue in persons with mild multiple sclerosis.
Neurorehabil Neural Repair. 2012 Oct;26(8):1015-21. doi: 10.1177/1545968312437943. Epub 2012 Mar 30.
3
Quantifying gait abnormalities in persons with multiple sclerosis with minimal disability.
Gait Posture. 2012 May;36(1):154-6. doi: 10.1016/j.gaitpost.2011.11.027. Epub 2012 Mar 17.
4
High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women.
Mult Scler. 2012 Sep;18(9):1334-6. doi: 10.1177/1352458512436596. Epub 2012 Feb 10.
5
Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010.
JAMA. 2012 Feb 1;307(5):491-7. doi: 10.1001/jama.2012.39. Epub 2012 Jan 17.
7
Oxygen cost of treadmill and over-ground walking in mildly disabled persons with multiple sclerosis.
Neurol Sci. 2011 Apr;32(2):255-62. doi: 10.1007/s10072-010-0396-0. Epub 2010 Aug 27.
8
The prevalence of overweight and obesity in veterans with multiple sclerosis.
Am J Phys Med Rehabil. 2009 Feb;88(2):83-91. doi: 10.1097/PHM.0b013e318194f8b5.
10
Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system.
Gait Posture. 2009 Jan;29(1):138-42. doi: 10.1016/j.gaitpost.2008.07.011. Epub 2008 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验